JAMDA
July 19, 2014
Showing 141 - 150 of 2685 results
Policy Snapshot
January 26, 2026
House Advances HHS Funding Bill With Key Health-Care Extensions
Last week, the House voted 341–88 to pass a bill providing full-year funding for the Department of Health and Human Services (HHS). The package includes several major health-care provisions and program extensions important to providers, patients, and long-term care stakeholders. The package is part of a De...
Policy Snapshot
May 10, 2024
House Ways & Means Committee Approves Telehealth Bills
Last week, the House Committee on Ways & Means held a mark-up hearing on several bills to protect and expand health care for millions of seniors. The committee approved six bills that address a wide range of pressing health-care issues, particularly those facing rural communities. The package of bills ...
JAMDA
May 22, 2023
Factors Associated With Benzodiazepine and Antipsychotic Prescribing in Hospice: A Qualitative Study of Hospice Prescribers
Benzodiazepine and antipsychotic medications are common components of the hospice toolkit and are routinely prescribed for behavioral symptom management at end of life. These medications have significant associated risks but, despite their frequent use, little is known about how clinicians weigh prescribin...
JAMDA
September 23, 2019
Optimizing Prescribing of Antipsychotics in Long-Term Care (OPAL): A Stepped-Wedge Trial
Inappropriate antipsychotic prescribing is a key quality indicator by which clinical outcomes might be monitored and improved in long-term care (LTC), but limited evidence exists on the most effective strategies for reducing inappropriate antipsychotic use.
JAMDA
April 28, 2015
The Mortality Risk of Conventional Antipsychotics in Elderly Patients: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials
Numerous observational studies have reported an increased risk of mortality for conventional antipsychotics in elderly patients, and for haloperidol in particular. Subsequently, health authorities have warned against use of conventional antipsychotics in dementia. Experimental evidence is lacking.
Caring for the Ages
April 6, 2026
OIG Launches Nursing Home Opioid Investigation: What Medical Directors Need to Know Now
The Office of Inspector General (OIG) for the U.S. Department of Health and Human Services has announced a new investigation examining possible opioid overuse, misuse, or diversion in nursing homes. While federal scrutiny of psychotropics in long-term care is familiar terrain, this initiative signals renew...
JAMDA
February 26, 2019
Fall Reduction Program in a Skilled Nursing Facility: a Multidisciplinary Approach
Caring for the Ages
June 4, 2019
A Multidisciplinary Approach to Fall Reduction in a Skilled Nursing Facility Wins the Howard Guterman Best Poster Award
JAMDA
February 7, 2014
Reduction of Antibiotic Starts for Asymptomatic Bacteriauria in Skilled Nursing Facilities
